Actually the CAPEX will be spread over several years and I expect will be relatively modest this year, apart from setting up the sales force in India. Couple that with a modest increase in revenue and it won't be a huge "loss". US will still be profitable, and there are other good announcements in the pipeline related to trials. So nope, it isn't worth wasting time reading some posters.
PNV - Chart, page-16688
-
- There are more pages in this discussion • 2,705 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.55 |
Change
-0.025(0.97%) |
Mkt cap ! $1.787B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.60 | $2.53 | $1.270M | 495.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 5519 | $2.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.55 | 12126 | 12 |
View Market Depth
| Last trade - 12.10pm 15/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |